Pharma Mar | PHM - Capital Ordinário





Capital Ordinário Alterar Data
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.49M 108K 2026-06
Almirall EUR 214.79M 0 2025-12
Dianthus Therapeutics USD 54.8M 215.59K 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
IQVIA Holdings USD 164.8M 200K 2026-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Moderna USD 391M 2M 2025-09
Organon & Co USD 262.62M 13K 2026-09
Pharma Mar EUR 17.34M 0 2026-09
Revvity USD 111.63M 174K 2026-06
Tectonic Therapeutic USD 19.24M 404.78K 2026-06
Viatris USD 1.16B 9.19M 2026-06
Xeris Pharmaceuticals USD 173.59M 1.03M 2026-06